Loading…
Particulate vaccines: on the quest for optimal delivery and immune response
Subunit vaccines offer a safer alternative to traditional organism-based vaccines, but their immunogenicity is impaired. This hurdle might be overcome by the use of micro- and nanodelivery systems carrying the antigen(s). This review discusses the rationale for the use of particulate vaccines and pr...
Saved in:
Published in: | Drug discovery today 2011-07, Vol.16 (13), p.569-582 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c424t-37146fa14decce389a21650afceca354aaa8a5a88ff43f179daaf0fcad4bb7bd3 |
---|---|
cites | cdi_FETCH-LOGICAL-c424t-37146fa14decce389a21650afceca354aaa8a5a88ff43f179daaf0fcad4bb7bd3 |
container_end_page | 582 |
container_issue | 13 |
container_start_page | 569 |
container_title | Drug discovery today |
container_volume | 16 |
creator | De Temmerman, Marie-Luce Rejman, Joanna Demeester, Jo Irvine, Darrell J. Gander, Bruno De Smedt, Stefaan C. |
description | Subunit vaccines offer a safer alternative to traditional organism-based vaccines, but their immunogenicity is impaired. This hurdle might be overcome by the use of micro- and nanodelivery systems carrying the antigen(s). This review discusses the rationale for the use of particulate vaccines and provides an overview of antigen-delivery vehicles currently under investigation. It further highlights the cellular uptake, antigen processing and the presentation by antigen-presenting cells because these processes are partially governed by particle characteristics and eventually determine the immunological outcome. Finally, we address the attractive concept of concomitant delivery of antigens and immunopotentiators. The condensed knowledge could be an asset for rationally designing antigen-delivery vehicles to obtain safe and efficacious vaccines.
Reviewing the rationale for the design of particulate vaccines and how particle characteristics influence internalization, processing and antigen presentation by APCs. |
doi_str_mv | 10.1016/j.drudis.2011.04.006 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_874018397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644611001334</els_id><sourcerecordid>1008846488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-37146fa14decce389a21650afceca354aaa8a5a88ff43f179daaf0fcad4bb7bd3</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhq2qCCjwD6rKl6q9JNjxJHF6QKoQtAik9kDP1qw9Vr3Kx9ZOVuLf4-0uHDnNHJ55Z-Zh7KMUpRSyuVyXLi4upLISUpYCSiGad-xU6lYXtVbV-9yruisagOaEfUhpLYSsuro5ZieVrFsBbX3K7n9jnINdepyJb9HaMFL6xqeRz3-J_1sozdxPkU-bOQzYc0d92FJ84jg6HoZhGYlHSptpTHTOjjz2iS4O9Yz9ub15vP5ZPPz6cXf9_aGwUMFcqFZC41GCI2tJ6Q4r2dQCvSWLqgZE1Fij1t6D8rLtHKIX3qKD1apdOXXGvuxzN3H6f6EZQrLU9zjStCSjWxBSq67N5Nc3SSmE1tCA1hmFPWrjlFIkbzYxfxyfMmR2ws3a7IWbnXAjwGTheezTYcOyGsi9Dr0YzsDnA4DJYu8jjjZnvHKgxC4vc1d7jrK5baBokg00WnIhkp2Nm8LblzwD8lmhuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1008846488</pqid></control><display><type>article</type><title>Particulate vaccines: on the quest for optimal delivery and immune response</title><source>Elsevier</source><creator>De Temmerman, Marie-Luce ; Rejman, Joanna ; Demeester, Jo ; Irvine, Darrell J. ; Gander, Bruno ; De Smedt, Stefaan C.</creator><creatorcontrib>De Temmerman, Marie-Luce ; Rejman, Joanna ; Demeester, Jo ; Irvine, Darrell J. ; Gander, Bruno ; De Smedt, Stefaan C.</creatorcontrib><description>Subunit vaccines offer a safer alternative to traditional organism-based vaccines, but their immunogenicity is impaired. This hurdle might be overcome by the use of micro- and nanodelivery systems carrying the antigen(s). This review discusses the rationale for the use of particulate vaccines and provides an overview of antigen-delivery vehicles currently under investigation. It further highlights the cellular uptake, antigen processing and the presentation by antigen-presenting cells because these processes are partially governed by particle characteristics and eventually determine the immunological outcome. Finally, we address the attractive concept of concomitant delivery of antigens and immunopotentiators. The condensed knowledge could be an asset for rationally designing antigen-delivery vehicles to obtain safe and efficacious vaccines.
Reviewing the rationale for the design of particulate vaccines and how particle characteristics influence internalization, processing and antigen presentation by APCs.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/j.drudis.2011.04.006</identifier><identifier>PMID: 21570475</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adjuvants, Immunologic - administration & dosage ; Animals ; Antigen presentation ; Antigen-Presenting Cells - immunology ; Antigens - administration & dosage ; Antigens - immunology ; Biological and medical sciences ; Drug Delivery Systems ; General pharmacology ; Humans ; Medical sciences ; Microspheres ; Nanoparticles ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Vaccines - administration & dosage ; Vaccines - adverse effects ; Vaccines - immunology ; Vaccines, Subunit - administration & dosage ; Vaccines, Subunit - adverse effects ; Vaccines, Subunit - immunology</subject><ispartof>Drug discovery today, 2011-07, Vol.16 (13), p.569-582</ispartof><rights>2011 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-37146fa14decce389a21650afceca354aaa8a5a88ff43f179daaf0fcad4bb7bd3</citedby><cites>FETCH-LOGICAL-c424t-37146fa14decce389a21650afceca354aaa8a5a88ff43f179daaf0fcad4bb7bd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24302011$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21570475$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Temmerman, Marie-Luce</creatorcontrib><creatorcontrib>Rejman, Joanna</creatorcontrib><creatorcontrib>Demeester, Jo</creatorcontrib><creatorcontrib>Irvine, Darrell J.</creatorcontrib><creatorcontrib>Gander, Bruno</creatorcontrib><creatorcontrib>De Smedt, Stefaan C.</creatorcontrib><title>Particulate vaccines: on the quest for optimal delivery and immune response</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>Subunit vaccines offer a safer alternative to traditional organism-based vaccines, but their immunogenicity is impaired. This hurdle might be overcome by the use of micro- and nanodelivery systems carrying the antigen(s). This review discusses the rationale for the use of particulate vaccines and provides an overview of antigen-delivery vehicles currently under investigation. It further highlights the cellular uptake, antigen processing and the presentation by antigen-presenting cells because these processes are partially governed by particle characteristics and eventually determine the immunological outcome. Finally, we address the attractive concept of concomitant delivery of antigens and immunopotentiators. The condensed knowledge could be an asset for rationally designing antigen-delivery vehicles to obtain safe and efficacious vaccines.
Reviewing the rationale for the design of particulate vaccines and how particle characteristics influence internalization, processing and antigen presentation by APCs.</description><subject>Adjuvants, Immunologic - administration & dosage</subject><subject>Animals</subject><subject>Antigen presentation</subject><subject>Antigen-Presenting Cells - immunology</subject><subject>Antigens - administration & dosage</subject><subject>Antigens - immunology</subject><subject>Biological and medical sciences</subject><subject>Drug Delivery Systems</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Microspheres</subject><subject>Nanoparticles</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Vaccines - administration & dosage</subject><subject>Vaccines - adverse effects</subject><subject>Vaccines - immunology</subject><subject>Vaccines, Subunit - administration & dosage</subject><subject>Vaccines, Subunit - adverse effects</subject><subject>Vaccines, Subunit - immunology</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P3DAQhq2qCCjwD6rKl6q9JNjxJHF6QKoQtAik9kDP1qw9Vr3Kx9ZOVuLf4-0uHDnNHJ55Z-Zh7KMUpRSyuVyXLi4upLISUpYCSiGad-xU6lYXtVbV-9yruisagOaEfUhpLYSsuro5ZieVrFsBbX3K7n9jnINdepyJb9HaMFL6xqeRz3-J_1sozdxPkU-bOQzYc0d92FJ84jg6HoZhGYlHSptpTHTOjjz2iS4O9Yz9ub15vP5ZPPz6cXf9_aGwUMFcqFZC41GCI2tJ6Q4r2dQCvSWLqgZE1Fij1t6D8rLtHKIX3qKD1apdOXXGvuxzN3H6f6EZQrLU9zjStCSjWxBSq67N5Nc3SSmE1tCA1hmFPWrjlFIkbzYxfxyfMmR2ws3a7IWbnXAjwGTheezTYcOyGsi9Dr0YzsDnA4DJYu8jjjZnvHKgxC4vc1d7jrK5baBokg00WnIhkp2Nm8LblzwD8lmhuw</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>De Temmerman, Marie-Luce</creator><creator>Rejman, Joanna</creator><creator>Demeester, Jo</creator><creator>Irvine, Darrell J.</creator><creator>Gander, Bruno</creator><creator>De Smedt, Stefaan C.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20110701</creationdate><title>Particulate vaccines: on the quest for optimal delivery and immune response</title><author>De Temmerman, Marie-Luce ; Rejman, Joanna ; Demeester, Jo ; Irvine, Darrell J. ; Gander, Bruno ; De Smedt, Stefaan C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-37146fa14decce389a21650afceca354aaa8a5a88ff43f179daaf0fcad4bb7bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adjuvants, Immunologic - administration & dosage</topic><topic>Animals</topic><topic>Antigen presentation</topic><topic>Antigen-Presenting Cells - immunology</topic><topic>Antigens - administration & dosage</topic><topic>Antigens - immunology</topic><topic>Biological and medical sciences</topic><topic>Drug Delivery Systems</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Microspheres</topic><topic>Nanoparticles</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Vaccines - administration & dosage</topic><topic>Vaccines - adverse effects</topic><topic>Vaccines - immunology</topic><topic>Vaccines, Subunit - administration & dosage</topic><topic>Vaccines, Subunit - adverse effects</topic><topic>Vaccines, Subunit - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Temmerman, Marie-Luce</creatorcontrib><creatorcontrib>Rejman, Joanna</creatorcontrib><creatorcontrib>Demeester, Jo</creatorcontrib><creatorcontrib>Irvine, Darrell J.</creatorcontrib><creatorcontrib>Gander, Bruno</creatorcontrib><creatorcontrib>De Smedt, Stefaan C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Temmerman, Marie-Luce</au><au>Rejman, Joanna</au><au>Demeester, Jo</au><au>Irvine, Darrell J.</au><au>Gander, Bruno</au><au>De Smedt, Stefaan C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Particulate vaccines: on the quest for optimal delivery and immune response</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>16</volume><issue>13</issue><spage>569</spage><epage>582</epage><pages>569-582</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>Subunit vaccines offer a safer alternative to traditional organism-based vaccines, but their immunogenicity is impaired. This hurdle might be overcome by the use of micro- and nanodelivery systems carrying the antigen(s). This review discusses the rationale for the use of particulate vaccines and provides an overview of antigen-delivery vehicles currently under investigation. It further highlights the cellular uptake, antigen processing and the presentation by antigen-presenting cells because these processes are partially governed by particle characteristics and eventually determine the immunological outcome. Finally, we address the attractive concept of concomitant delivery of antigens and immunopotentiators. The condensed knowledge could be an asset for rationally designing antigen-delivery vehicles to obtain safe and efficacious vaccines.
Reviewing the rationale for the design of particulate vaccines and how particle characteristics influence internalization, processing and antigen presentation by APCs.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>21570475</pmid><doi>10.1016/j.drudis.2011.04.006</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1359-6446 |
ispartof | Drug discovery today, 2011-07, Vol.16 (13), p.569-582 |
issn | 1359-6446 1878-5832 |
language | eng |
recordid | cdi_proquest_miscellaneous_874018397 |
source | Elsevier |
subjects | Adjuvants, Immunologic - administration & dosage Animals Antigen presentation Antigen-Presenting Cells - immunology Antigens - administration & dosage Antigens - immunology Biological and medical sciences Drug Delivery Systems General pharmacology Humans Medical sciences Microspheres Nanoparticles Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Vaccines - administration & dosage Vaccines - adverse effects Vaccines - immunology Vaccines, Subunit - administration & dosage Vaccines, Subunit - adverse effects Vaccines, Subunit - immunology |
title | Particulate vaccines: on the quest for optimal delivery and immune response |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A02%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Particulate%20vaccines:%20on%20the%20quest%20for%20optimal%20delivery%20and%20immune%20response&rft.jtitle=Drug%20discovery%20today&rft.au=De%20Temmerman,%20Marie-Luce&rft.date=2011-07-01&rft.volume=16&rft.issue=13&rft.spage=569&rft.epage=582&rft.pages=569-582&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/j.drudis.2011.04.006&rft_dat=%3Cproquest_cross%3E1008846488%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c424t-37146fa14decce389a21650afceca354aaa8a5a88ff43f179daaf0fcad4bb7bd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1008846488&rft_id=info:pmid/21570475&rfr_iscdi=true |